NIH Women's Health Researchers Rebut Criticisms Of Their Study

Project scientists reject Institute of Medicine claims that their ambitious initiative is scientifically and financially deficient One of the main questions that Women's Health Initiative (WHI) investigators hope to answer, and one specifically challenged by the Institute of Medicine (IOM), is whether a low-fat diet will reduce breast cancer risk. This hypothesis arises from comparisons of epidemiological data from countries with

Written byFranklin Hoke
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Project scientists reject Institute of Medicine claims that their ambitious initiative is scientifically and financially deficient One of the main questions that Women's Health Initiative (WHI) investigators hope to answer, and one specifically challenged by the Institute of Medicine (IOM), is whether a low-fat diet will reduce breast cancer risk. This hypothesis arises from comparisons of epidemiological data from countries with different fat-consumption patterns and of data tracking the change in breast cancer occurrence among migrants moving between some of these countries. Japanese women, for example, have much lower breast cancer rates than do women in the United States, and the traditional Japanese diet contains much less fat than is the norm in the U.S. Women whose parents moved from Japan to the U.S. have breast cancer rates comparable with those of other women in the U.S. The IOM report, however, suggested that these comparisons are based on the amount ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies